Patient Safety Blog

Direct-to-Patient Pharmaceutical Programs

October 15, 2025

The pharmaceutical landscape is evolving rapidly, and one of the most transformative shifts is the rise of direct-to-patient (D2P) distribution. As manufacturers seek to bypass traditional channels and deliver medications straight to patients’ doors, the […]

Publications

Technical Visit Guidelines for the Biopharmaceutical Industry

October 13, 2025

Get guidance from subject matter experts on the requirements, execution, and management of the “technical visit”, as a tool in the supplier quality manager’s toolbox, and as it compares to the “quality audit”. The publication […]

Patient Safety Blog

Clarifying QMS Relevancy: Why We Need Industry Guidance Now

September 18, 2025

In the world of regulated industries—Quality Management Systems (QMS) are the backbone of consistent, safe, and effective operations. But here’s the catch: the language in ISO and other standards often leaves too much room for […]

Publications

SCAR – Supplier Corrective Action Report Programs: A Practical Guide Developed by the Supplier Quality Working Group

July 30, 2025

‘SCAR’ gives pharmaceutical industry professionals a framework for handling improvements that they demand from their suppliers (i.e., vendors) based on regulations and/or the outsourcing entity’s own quality standards. This guide includes a template SCAR form […]

Patient Safety Blog

Patient Safety Blog – How to Plan for the Unplannable

April 30, 2025

Life sciences and healthcare organizations must have comprehensive risk management and crisis management plans that can provide for proactive risk scenario planning and a rapid response to supply chain emergencies. They also need to develop […]

Patient Safety Blog

What We Read

April 25, 2025

Decision making might be tougher now than it has been for most of our careers. Today, we all have unprecedented needs for reliable info sources. “Grassroots” style info sharing is proving to be a critical […]

Publications

Real Value of Rx-360’s Consortium Membership and Joint Audit Program

March 11, 2025

Read the 2024 Case Study – showing significant budget relief that came from Rx-360’s programs and consortium membership on a major player in biotech, chemical manufacturing, and life sciences.

Rx-360 Insights

Rx-360 Announces Approval as a Pilot Center of Excellence for the APEC Regulatory Harmonization Steering Committee

October 4, 2024

Rx-360® is pleased to announce that it has been accepted as a Pilot Center of Excellence (CoE) for the APEC Regulatory Harmonization Steering Committee. The pilot will be focused on the Global Medical Product Supply Chain Integrity Priority Work Area Roadmap.